Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER

AUSTIN, Texas, March 20, 2017 -- (Healthcare Sales & Marketing Network) -- Pain Therapeutics, Inc. (PTIE) today announced positive regulatory guidance from a recent meeting with the U.S. Food and Drug Administration (FDA) regarding REMOXY (extended-release... Biopharmaceuticals, Drug Delivery, FDA Pain Therapeutics, REMOXY, extended-release, oxycodone
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news